Top news of the week: 28.09.2023.
Three Mass. startups are finalists in national inventor competition
Diverging from the tech and biotech sectors, the companies are focused on making it easier to turn existing dams into power sources, making artificial leather, and detecting brain swelling.
Immutep Limited (ASX:IMM): Is Breakeven Near?
Immutep Limited ( ASX:IMM ) is possibly approaching a major achievement in its business, so we would like to shine some...
Big pharma can’t get enough of one class of cancer drugs
A spate of dealmaking suggests high expectations for antibody-drug conjugates
Cambridge picked as a national hub for new federal health research agency
The agency, dubbed ARPA-H, is seeking to spend billions on breakthroughs for tough-to-cure diseases like cancer and Alzheimer’s.
Jim Cramer’s guide to investing: How to spot a flash crash
CNBC's Jim Cramer examined two recent flash crashes.
Comparative physicochemical, hormonal, transcriptomic and proteomic analyses provide new insights into the formation mechanism of two chemotypes of Pogostemon cablin
Patchouli (Pogostemon cablin) is an aromatic plant, and its oil has diverse applications in medicine, food, and cosmetics. Patchouli alcohol is the principal bioactive constituent of its ...
CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infection
Author summary The ultimate goal of human immunodeficiency virus (HIV) therapeutic development is to enable HIV+ individuals to stop taking daily lifelong antiretroviral therapeutics (ART) ...
Osteoprotegerin genetic polymorphisms and their influence on therapeutic response to ibandronate in postmenopausal osteoporotic females
Objectives The present study investigated osteoprotegerin (OPG) genetic polymorphisms and their influence on the therapeutic response to ibandronate in postmenopausal osteoporotic females. ...